A specific FABP4 inhibitor BMS309403 can effectively protect against diabetes mellitus, insulin resistance, and atherosclerosis in mouse model, which suggests that chemical inhibitors of FABP4 may become an effective therapeutic strategy [32]. This evidence concerns the gene FABP4 and diabetes mellitus.